Pancreatic Cancer Research

ResearcherUniversity of LiverpoolActive in the last 2 years

Dylan Williams

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-8672-9818; OpenAlex author ID A5102111326. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer. Co-author DOI 10.1093/jnci/djaf345↗
  2. The role of Nrf2 in pancreatic cancer and the evaluation of brusatol as a chemotherapeutic agent Co-author DOI 10.17638/03096696↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lucy S. Oldfield · 1 shared paper, 2026 · strength 0.22
  2. Paula Ghaneh · 1 shared paper, 2026 · strength 0.22
  3. Markus Wolfgang Büchler · 1 shared paper, 2026 · strength 0.22
  4. Pedro Antonio Pérez-Mancera · 1 shared paper, 2026 · strength 0.22
  5. Thilo Hackert · 1 shared paper, 2026 · strength 0.22
  6. Christoph Springfeld · 1 shared paper, 2026 · strength 0.22
  7. Lawrence N. Barrera · 1 shared paper, 2026 · strength 0.22
  8. Kate Murray · 1 shared paper, 2026 · strength 0.22
  9. John P. Neoptolemos · 1 shared paper, 2026 · strength 0.22
  10. William Greenhalf · 1 shared paper, 2026 · strength 0.22
  11. Christoph W. Michalski · 1 shared paper, 2026 · strength 0.22
  12. Christopher Michael Halloran · 1 shared paper, 2026 · strength 0.22
  13. Daniel H. Palmer · 1 shared paper, 2026 · strength 0.22
  14. Eithne Costello · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.